1. Introduction {#sec1-nutrients-10-00648}
===============

Inflammation contributes to the pathophysiology of many chronic diseases, such as obesity, metabolic syndrome (MetS), diabetes, and cardiovascular disease \[[@B1-nutrients-10-00648],[@B2-nutrients-10-00648],[@B3-nutrients-10-00648]\]. Continuous chronic stress exposure leads to chronic low-grade inflammation \[[@B4-nutrients-10-00648]\]. Since inflammatory adipokines and cytokines are increased, and anti-inflammatory adipokines and cytokines are reduced, in an inflammatory environment, various metabolic disorders occur over time, resulting in MetS \[[@B4-nutrients-10-00648],[@B5-nutrients-10-00648]\]. Various factors, such as age, sex, exercise, smoking, and diet are involved in the progression of this inflammatory process \[[@B4-nutrients-10-00648]\]. Diet is considered a powerful modulator of low-grade inflammatory conditions because it can affect the balance between pro- and anti-inflammatory cytokines and adipokines \[[@B2-nutrients-10-00648],[@B4-nutrients-10-00648],[@B5-nutrients-10-00648]\].

MetS consists of several factors, including hypertension, hyperglycemia, hypertriglyceridemia, abdominal obesity, and low high-density lipoprotein (HDL) cholesterol \[[@B6-nutrients-10-00648]\]. The incidence of MetS has increased globally with obesity and sedentary lifestyles \[[@B7-nutrients-10-00648]\]. MetS and its components have become a major public health concern, as they are known risk factors for type 2 diabetes and heart disease \[[@B7-nutrients-10-00648],[@B8-nutrients-10-00648]\].

The dietary inflammatory index (DII) was recently developed and is used to calculate the overall inflammatory potential of a diet \[[@B9-nutrients-10-00648]\]. The DII was developed based on the relationship between various dietary factors and blood inflammatory biomarkers that have been reported in the literature \[[@B9-nutrients-10-00648]\]. Several studies have reported a close association between the DII and inflammatory biomarkers \[[@B10-nutrients-10-00648],[@B11-nutrients-10-00648],[@B12-nutrients-10-00648],[@B13-nutrients-10-00648]\]. A high DII value is associated with increased high-sensitivity c-reactive protein, interleukin-6, homocysteine, and tumor necrosis factor-α levels \[[@B10-nutrients-10-00648],[@B11-nutrients-10-00648],[@B12-nutrients-10-00648],[@B13-nutrients-10-00648]\].

If the inflammatory potential of a diet is high, inflammation-associated MetS may occur easily. In a prospective French study, an inflammatory diet with a high DII value was associated with an increased risk of developing MetS \[[@B14-nutrients-10-00648]\]. However, several other prospective and cross-sectional studies from different countries revealed no association between the DII and MetS prevalence \[[@B15-nutrients-10-00648],[@B16-nutrients-10-00648],[@B17-nutrients-10-00648],[@B18-nutrients-10-00648],[@B19-nutrients-10-00648]\]. Other studies have reported that the DII is related to only some components of MetS \[[@B20-nutrients-10-00648],[@B21-nutrients-10-00648]\]. In this study, we aimed to investigate the relationship between the DII and MetS in Korean adults using the most recent nationally representative survey data.

2. Material and Methods {#sec2-nutrients-10-00648}
=======================

2.1. Study Subjects {#sec2dot1-nutrients-10-00648}
-------------------

This study was conducted based on data from the sixth (2013--2015) Korea National Health and Nutrition Examination Survey (KNHANES). The KNHANES is a nationally representative, cross-sectional survey conducted by the Korea Centers for Disease Control and Prevention (KCDCP) \[[@B22-nutrients-10-00648]\]. The KNHANES involves a complex, stratified, multistage probability sampling design. A total of 13525 Korean adults, 19--65 years old, were selected. Among these participants, those who did not respond to the daily dietary survey by the 24-h method were excluded (*n* = 1724). The following participants were also excluded: those who had an energy intake \<500 or \>5000 kcal/day (*n* = 223); those with incomplete anthropometric data or biochemical data for the diagnosis of MetS (*n* = 1589); and those who did not have the demographic variables or lifestyle data needed for statistical correction (*n* = 698). As a result, 9291 subjects were included in the final analysis. All participants provided written informed consent, and the survey was approved by the Institutional Review Board (IRB) of the KCDCP (2013-07CON-03-4C and 2013-12EXP-03-5C). This study was conducted after research ethics approval was obtained (YIIRB No. 2-1040966-AB-N-01-20-1712-HSR-092-8).

2.2. Measurement of Dietary Intake and Other Variables {#sec2dot2-nutrients-10-00648}
------------------------------------------------------

Food and nutrient intake was assessed from the 24-h dietary recall data. Dietary data were collected from each participant by interviewers trained by the Korea Centers for Disease Control and Prevention (KCDCP). Information on sociodemographic characteristics and health-related variables was obtained during the health interview using a questionnaire. Regarding alcohol consumption, participants were categorized as non-drinkers or ever-drinkers, and for smoking status, as non-smokers (smoked less than 5 packs ever) or smokers. Regular physical activity was defined as at least 30 min per day for 5 days per week at a moderate intensity. To identify education level, the participant was identified as an elementary or middle school graduate, high school graduate, or college graduate.

2.3. Measurements of Metabolic Risk Factors {#sec2dot3-nutrients-10-00648}
-------------------------------------------

Height and weight were measured to the nearest 0.1 cm and 0.1 kg, respectively; the participants wore light clothing and no shoes. Body mass index (BMI) was calculated as the weight in kilograms divided by the square of the height in meters (kg/m^2^). Waist circumference (cm) was measured at the midpoint between the inferior margin of the last rib and the iliac crest in a horizontal plane.

Blood samples were collected in the morning after the participant had fasted for at least 8 h. Fasting plasma glucose, triglyceride, and HDL cholesterol levels (mg/dL) were measured enzymatically using a Hitachi automatic analyzer 7600 (Hitachi, Tokyo, Japan) in central, certified laboratories. Blood pressure was measured with a Baumanometer mercury sphygmomanometer (W.A. Baum, Copiague, NY, USA). Three systolic blood pressure (SBP) and diastolic blood pressure (DBP) readings were recorded, and the average of the last two readings was used for data analysis.

2.4. Definition of Metabolic Syndrome {#sec2dot4-nutrients-10-00648}
-------------------------------------

MetS was diagnosed, based on the Modified National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) and the obesity guidelines of the Obesity Society of Korea, as ≥3 of any of the following \[[@B23-nutrients-10-00648],[@B24-nutrients-10-00648]\]: (1) abdominal obesity (WC ≥90 cm for men or ≥85 cm for women); (2) high blood pressure (SBP/DBP ≥130/85 mmHg or the use of antihypertensive medication); (3) hypertriglyceridemia (triglyceride level ≥150 mg/dL); (4) hyperglycemia (fasting plasma glucose ≥100 mg/dL or current use of insulin or oral hypoglycemia medication, or a physician's diagnosis); and (5) low HDL-cholesterol level (\<40 mg/dL in men or \<50 mg/dL in women).

2.5. Calculation of Dietary Inflammation Index {#sec2dot5-nutrients-10-00648}
----------------------------------------------

The inflammatory potential of the diet was calculated using the DII developed by Shivappa et al. \[[@B9-nutrients-10-00648]\]. The DII development details \[[@B9-nutrients-10-00648]\] and construct validation \[[@B10-nutrients-10-00648],[@B11-nutrients-10-00648],[@B12-nutrients-10-00648],[@B13-nutrients-10-00648]\] have been previously described. The 24-h dietary recall data were used to calculate the *z*-score for each of the food parameters for each individual. The global means and standard deviations of the food and nutrient intakes collected from the 11 nations, including Korea, were used to calculate the *z*-score \[[@B9-nutrients-10-00648]\]. The *z*-score was then converted to a percentile and centered by doubling the value and subtracting 1. The centered percentile value was multiplied by the respective inflammatory effect score to obtain the food parameter-specific DII score \[[@B9-nutrients-10-00648]\]. The overall DII score was calculated as the sum of all the available food parameter-specific DII scores. In this study, data on 23 of the original 45 DII food parameters were available and were used for DII calculation. These parameters included seven proinflammatory components (energy, carbohydrates, protein, total fat, saturated fatty acids, cholesterol, and iron) and 16 anti-inflammatory components (monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), n-3 fatty acids, n-6 fatty acids, fiber, vitamin A, β-carotene, thiamin, riboflavin, niacin, vitamin C, garlic, ginger, onion, tea, and pepper). Parameters not yet available in the KNHANES data due to an incomplete food database or very low intake were not included in the DII calculation. Energy-adjusted values, which were obtained using the residual method, were used \[[@B25-nutrients-10-00648]\]. A low DII value indicates that the diet has low inflammatory potential.

2.6. Statistical Analyses {#sec2dot6-nutrients-10-00648}
-------------------------

All statistical analysis accounted for the complex sampling designs and used appropriate sampling weights, using PROC SURVEY in the Statistical Analysis Systems (SAS) program to make estimates of the entire Korean adult population from the representative survey sample. Categorical variables were expressed as frequencies and percentages, and continuous variables were expressed as the means and standard errors. To determine differences in the variables according to sex, *t*-tests were used for continuous variables, and the chi-square test, for categorical variables.

The DII was categorized into quartiles according to the distribution of the subjects by sex. Differences across the DII quartiles by sex were determined using chi-square tests (categorical variables) or ANOVA (continuous variables). Logistic regression analysis was performed to determine odds ratios (ORs) and 95% confidence intervals (CIs) for MetS and its components according to the DII quartiles. The bottom DII quartile (Q1) was used as a reference category. In the multivariable-adjusted model, age, body mass index (BMI), education, smoking, alcohol consumption, physical activity, and total energy intake were considered as potential confounders. Linear trends across the DII were tested by assigning the median value of the category to each participant and modeling this value as a continuous variable. A stratified analysis using menopausal status was performed to examine the possibility of effect modification by menopausal status. SAS 9.4 software (SAS Institute, Inc., Cary, NC, USA) was used to perform the calculations; a 2-sided *p* value less than 0.05 was considered statistically significant.

3. Results {#sec3-nutrients-10-00648}
==========

The characteristics of the study participants are presented in [Table 1](#nutrients-10-00648-t001){ref-type="table"}. A total of 9291 subjects (3682 men and 5609 women) were studied with a mean age of 41.3 years. The BMI (kg/m^2^) of the subjects was 23.7, and the mean energy intake was 2136.2 kcal. Men were more likely than women to consume alcohol, smoke, and engage in aerobic activity. The mean DII score, waist circumference, systolic and diastolic blood pressure, blood triglyceride and fasting glucose levels were higher in men than in women. However, blood HDL cholesterol levels were higher in women than in men. The prevalence of MetS was higher in men (26.5%) than in women (14.9%).

Lifestyle characteristics and nutrient and food intake according to the DII quartiles stratified by sex are shown in [Table 2](#nutrients-10-00648-t002){ref-type="table"}. In both men and women, subjects with high DII values were younger, more likely to drink alcohol, and had higher energy intake levels than those with low DII values. In men, subjects with high DII values had a lower BMI than those with low DII values. In women, subjects with high DII values were more likely to be current smokers than those with low DII values. Nutrient and food intake trends according to the DII quartile were similar for both sexes. Compared with those in the bottom DII quartile, subjects in the top DII quartile had a higher proportion of energy intake from carbohydrates and a lower proportion of energy intake from protein. Additionally, subjects in the top DII quartile had a higher intake of saturated fat, MUFA, and cholesterol but a lower intake of PUFA and n-3 fatty acids. Subjects with high DII values also had significantly reduced fiber, iron, and vitamin intake. Garlic, ginger, onion, tea, and pepper intake were also significantly reduced in subjects with high DII values.

[Table 3](#nutrients-10-00648-t003){ref-type="table"} presents the ORs of MetS and its components according to DII quartiles. In the crude model, DII was not associated with MetS prevalence in either men or women. In the multivariable-adjusted logistic regression model, the top DII quartile (Q4) was positively associated with MetS prevalence only in men (Q4 vs. Q1, OR = 1.40; 95% CI = 1.06--1.85; *p* for linear trend = 0.008) after controlling for age, BMI, education, alcohol consumption, smoking, physical activity, and total calorie intake. Among men, the top DII quartile was also positively associated with the prevalence of hyperglycemia (Q4 vs. Q1, OR = 1.30; 95% CI = 1.02--1.65; p for linear trend = 0.038).

When women were stratified by menopausal status, an association between the DII and MetS prevalence was identified in postmenopausal women ([Figure 1](#nutrients-10-00648-f001){ref-type="fig"}). The top DII quartile (Q4) was positively associated with MetS prevalence (Q4 vs. Q1, OR = 1.67; 95% CI = 1.15--2.44; p for linear trend = 0.008) and central obesity prevalence (Q4 vs. Q1, OR = 1.75; 95% CI = 1.07--2.88; p for linear trend = 0.070) in postmenopausal women after controlling for confounding factors.

4. Discussion {#sec4-nutrients-10-00648}
=============

In this study, we used the nationally representative KNHANES data to investigate the association between the DII and MetS in Korean adults. The DII was significantly associated with MetS prevalence in men and postmenopausal women. The DII was also positively associated with the prevalence of hyperglycemia in men and central obesity in postmenopausal women.

Several studies have examined the association between DII and MetS, and the results to date have been inconsistent. The prospective Supplementation en Vitamines et Mineraux AntioXydants (SUVIMAX) cohort study in France \[[@B14-nutrients-10-00648]\] examined the association between the DII and MetS outcomes in 3726 subjects. The authors found an increased risk of developing MetS with high DII values (OR compared Q4 to Q1 was 1.39, 95% CI = 1.01--1.92) after an average follow-up of 12.4 years. Another prospective study of a Spanish cohort of university graduates (SUN) assessed the association between different dietary indexes and MetS incidence after a median follow-up of 8.3 years (*n* = 6851) \[[@B15-nutrients-10-00648]\]. They found that the Pro-Vegetarian Diet was significantly associated with a lower risk of developing MetS, but no significant association was found between the DII and MetS. Several other cross-sectional studies, including the Polish-Norwegian (PONS) study (*n* = 3862), Buffalo Cardio-Metabolic Occupational Police Stress (BCOPS) study (*n* = 464), Luxembourg study (*n* = 1352), and Lebanese study (*n* = 331), also assessed the association between the DII and MetS and found no significant association \[[@B16-nutrients-10-00648],[@B17-nutrients-10-00648],[@B18-nutrients-10-00648],[@B19-nutrients-10-00648]\]. Overall, only one longitudinal study (SUVIMAX) and one cross-sectional study (the present work) have found a positive association between DII and MetS; no other studies have found a link between DII and MetS.

The inconsistent results regarding the association between the DII and MetS might be due to several reasons, such as differences in population, diet, study design, sample size, and age \[[@B14-nutrients-10-00648],[@B15-nutrients-10-00648],[@B16-nutrients-10-00648],[@B17-nutrients-10-00648],[@B18-nutrients-10-00648],[@B19-nutrients-10-00648]\]. It is also possible that the inconsistent results among studies may be due, in part, to different dietary data collection methods and available food parameters used to calculate DII. The present study used 24-h dietary recall of the participants to collect dietary data and used 23 dietary parameters that included anti-inflammatory foods, such as garlic, onion, pepper, and tea, as well as nutrient parameters to calculate DII. Other dietary parameters were not used in this study because of an incomplete food database or very low intake. The SUVIMAX study \[[@B14-nutrients-10-00648]\] used 24-h dietary records to obtain 36 food parameters, including anti-inflammatory foods and flavonoids. Other MetS studies \[[@B15-nutrients-10-00648],[@B16-nutrients-10-00648],[@B17-nutrients-10-00648],[@B18-nutrients-10-00648],[@B19-nutrients-10-00648]\], on the other hand, obtained 22--28 parameters in a food frequency questionnaire and did not include anti-inflammatory spice parameters.

Anti-inflammatory foods, such as pepper, onion, garlic, and tea, have been consumed in large quantities for a long time in Korea. In this study, the lower DII quartile (Q1) consumed much more pepper, garlic, onion, and tea than the upper DII quartile (Q4). Pepper (capsaicin) consumption has been linked to cardiovascular health by improving endothelial function, reducing body fat, and increasing the resistance of lipoprotein to oxidation \[[@B26-nutrients-10-00648],[@B27-nutrients-10-00648]\]. The administration of aged garlic extract increased adiponectin, an anti-inflammatory adipokine with cardioprotective properties \[[@B28-nutrients-10-00648]\]. Onion was effective as a cholesterol-lowering food agent \[[@B29-nutrients-10-00648]\]. Green tea also increased adiponectin and decreased pro-inflammatory serum amyloid alpha \[[@B30-nutrients-10-00648],[@B31-nutrients-10-00648]\]. The high intake of these anti-inflammatory foods may have increased the synergy of anti-inflammatory potential to inhibit the development of MetS. The contribution of each anti-inflammatory food to MetS development has not been investigated, and further research is needed in the future.

The Mediterranean diet and DASH diet have been reported to lower MetS prevalence \[[@B8-nutrients-10-00648],[@B32-nutrients-10-00648]\]. Components of these healthy dietary patterns that may contribute to reducing MetS development include whole grains, fruits and vegetables, dairy products, and n-3 fatty acids \[[@B33-nutrients-10-00648],[@B34-nutrients-10-00648],[@B35-nutrients-10-00648]\]. In our study, fiber intake, vitamin A, vitamin C, n-3 fatty acids, and PUFA were included as DII components, and intake of these nutrients was inadequate in high inflammatory quartiles. Thus, some of the effects that the DII may have on MetS development are associated with factors that decrease MetS in a healthy eating pattern.

The association between the DII and MetS was more pronounced in postmenopausal women than in premenopausal women. After menopause, the lack of estrogen has been shown to alter fat metabolism and promote MetS \[[@B36-nutrients-10-00648]\]. Thus, dietary inflammatory potential appears to have an increased impact on postmenopausal women who are prone to developing MetS.

The association between the DII and metabolic risk factors has been examined in several studies. In the prospective SUVIMAX study \[[@B15-nutrients-10-00648]\], high DII scores were associated with increased triglyceride levels and blood pressure and reduced HDL cholesterol levels. In the cross-sectional BCOPS study \[[@B17-nutrients-10-00648]\], the glucose intolerance component was affected by a pro-inflammatory diet. In the PREvención con DIeta MEDiterránea (PREDIMED) cross-sectional study in Spain \[[@B20-nutrients-10-00648]\], the DII was associated with abdominal obesity in women, even after controlling for adherence to the Mediterranean diet, showing a clear relationship between dietary inflammation and abdominal obesity. In a longitudinal study of Australian adults \[[@B21-nutrients-10-00648]\], more inflammatory diets were associated with an increased risk of hypertension, suggesting that inflammation adversely affects blood vessels and kidneys, leading to hypertension \[[@B37-nutrients-10-00648]\]. In the Luxembourg and Lebanese studies, however, no association was observed between the DII and metabolic risk factors \[[@B18-nutrients-10-00648],[@B19-nutrients-10-00648]\]. The association between DII and metabolic risk factors varied from study to study, and further studies are needed to form a clear conclusion.

In the present study, we found a sex and age difference in the effects of a pro-inflammatory diet on metabolic risk factors. The DII was associated with hyperglycemia in men. The DII was also associated with central obesity in postmenopausal women, but not in premenopausal women. The reasons why the DII has different effects on metabolic risk factors depending on sex and age are unclear. The first possible reason is that postmenopausal women have more body fat than premenopausal women, and this body fat, especially abdominal fat, is thought to be involved in producing many inflammatory markers in the body \[[@B38-nutrients-10-00648]\]. Second, sex hormones may influence the level of inflammatory markers and the regulation of metabolic risk factors \[[@B39-nutrients-10-00648],[@B40-nutrients-10-00648]\].

The strengths of this study are as follows: The KNHANES is a nationally representative survey; the sample size (*n* = 9291) of this study was large. However, the following are some limitations of our study. First, the cross-sectional design of this study essentially limited causal inferences. Second, we used data from a single 24-h recall, which may not represent the usual intake of the subject. Third, only 23 out of 45 original dietary inflammatory parameters were available to calculate the DII. Fourth, we did not have information on specific hypertriglyceridemia and HDL-cholesterol medications taken by the subjects to include in the MetS criteria. Fifth, the associations between the DII and MetS found in this study cannot be generalized to populations with very different dietary styles.

5. Conclusions {#sec5-nutrients-10-00648}
==============

The DII was significantly associated with MetS prevalence after controlling for various confounding factors in Korean men and postmenopausal women. The DII was also positively associated with the prevalence of hyperglycemia in men and central obesity in postmenopausal women. Further prospective cohort studies should be conducted before a causal association between the DII and MetS can be concluded.
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nutrients-10-00648-t001_Table 1

###### 

General characteristics of the subjects. ^1.^

  Characteristics                       Total (*n* = 9291)   Men (*n* = 3682)   Women (*n* = 5609)   *p*-Value ^2^
  ------------------------------------- -------------------- ------------------ -------------------- ---------------
  Age (years)                           41.3 ± 0.2           40.9 ± 0.2         41.8 ± 0.2           0.002
  BMI (body mass index, kg/m^2^)        23.7 ± 0.0           24.5 ± 0.1         23.0 ± 0.1           \<0.001
  Energy intake (kcal/day)              2136.2 ± 11.4        2463.7 ± 17.2      1810.3 ± 10.6        \<0.001
  Education                                                                                          
    ≤Middle school                      1907 (16.0)          625 (12.8)         1282 (19.2)          \<0.001
    High school                         3675 (41.7)          1474 (42.8)        2201 (40.6)          
    ≥University                         3709 (42.3)          1583 (44.4)        2126 (40.3)          
  Alcohol consumption                   8525 (93.2)          3556 (96.6)        4969 (89.9)          \<0.001
  Smoking                               3153 (39.4)          2666 (69.8)        487 (9.2)            \<0.001
  Physical activity                     3883 (45.1)          1659 (48.1)        2224 (42.0)          \<0.001
  Metabolic syndrome                    2009 (20.7)          1043 (26.5)        966 (14.9)           \<0.001
  Waist circumference (cm) ^3^          80.7 ± 0.1           85.4 ± 0.2         76.9 ± 0.2           \<0.001
  Systolic blood pressure (mmHg) ^3^    114.3 ± 0.2          118.9 ± 0.3        111.7 ± 0.2          \<0.001
  Diastolic blood pressure (mmHg) ^3^   75.6 ± 0.2           79.2 ± 0.2         73.1 ± 0.2           \<0.001
  Triglyceride (mg/dL) ^3^              135.5 ± 1.5          170.5 ± 2.6        108.5 ± 1.1          \<0.001
  Fasting glucose (mg/dL) ^3^           97.3 ± 0.3           101.2 ± 0.4        95.9 ± 0.3           \<0.001
  HDL cholesterol (mg/dL) ^3^           51.5 ± 0.1           47.1 ± 0.2         55.2 ± 0.2           \<0.001
  Dietary inflammatory index score      0.56 ± 0.02          0.88 ± 0.03        0.25 ± 0.03          \<0.001

All analyses accounted for the complex sampling design and appropriate sampling weights of the national survey. ^1^ Data are expressed as the number of subjects for each category (weighted percentage) or means ± SE (standard error). ^2^ All *p*-values represent differences between men and women, *p*-values are from the chi-square test for categorical variables and t-test for continuous variables. ^3^ Means ± SE were adjusted for age and sex.

nutrients-10-00648-t002_Table 2

###### 

Characteristics and nutrient and food intake of the subjects according to DII quartiles.

                              Men             Women                                                                                                                       
  --------------------------- --------------- --------------- --------------- --------------- --------- ---------------- ---------------- --------------- --------------- ---------
  Age (years)                 43.8 ± 0.5      41.8 ± 0.4      40.6 ± 0.5      37.7 ± 0.5      \<0.001   45.9 ± 0.3       43.0 ± 0.4       41.3 ± 0.4      37.3 ± 0.4      \<0.001
  BMI (kg/m^2^)               24.9 ± 0.1      24.4 ± 0.1      24.5 ± 0.1      24.2 ± 0.1      0.001     23.1 ± 0.1       23.0 ± 0.1       22.9 ± 0.1      22.8 ± 0.1      0.205
  Education level                                                                                                                                                         
     ≤Middle school           169(14.3)       147(12.3)       165(13.6)       144(11.1)       \<0.001   335(21.2)        350(20.6)        326(19.9)       271(15.4)       0.001
     High school              311(35.5)       351(40.0)       384(44.5)       428(50.3)                 580(42.7)        528(38.3)        531(39.0)       562(42.2)       
     ≥University              440(50.2)       423(47.7)       371(41.9)       349(38.6)                 488(36.2)        524(41.0)        545(41.1)       569(42.4)       
  Alcohol consumption (yes)   875(95.2)       875(95.2)       897(97.7)       893(97.1)       0.048     1218(88.1)       1233(89.4)       1248(90.1)      1270(91.7)      0.029
  Smoking (yes)               660(69.2)       651(68.3)       673(71.3)       682(70.4)       0.605     80(6.4)          107(8.4)         130(9.7)        170(11.9)       \<0.001
  Physical activity (yes)     402(46.1)       420(48.3)       413(47.3)       424(50.6)       0.296     605(45.3)        575(43.0)        498(37.7)       546(42.2)       0.005
  Energy (kcal)               2058.4 ± 28.1   2425.2 ± 31.3   2585.4 ± 31.2   2745.6 ± 32.4   \<0.001   1587.9 ± 17.3    1745.5 ± 19.4    1872.4 ± 20.8   2006.9 ± 23.6   \<0.001
     % carbohydrates          64.7 ± 0.4      65.6 ± 0.4      66.3 ± 0.4      67.1 ± 0.4      \<0.001   63.9 ± 0.3       66.6 ± 0.3       66.3 ± 0.3      66.1 ± 0.3      \<0.001
     % protein                15.3 ± 0.1      14.5 ± 0.1      13.6 ± 0.1      12.6 ± 0.1      \<0.001   15.3 ± 0.1       13.9 ± 0.1       13.7 ± 0.1      12.9 ± 0.1      \<0.001
     % fat                    20.0 ± 0.3      19.9 ± 0.3      20.1 ± 0.3      20.2 ± 0.3      0.936     20.8 ± 0.3       19.5 ± 0.2       20.0 ± 0.3      21.0 ± 0.3      \<0.001
  Saturated fat (g)           12.2 ± 0.3      15.3 ± 0.4      17.5 ± 0.4      20.6 ± 0.5      \<0.001   9.5 ± 0.2        10.7 ± 0.2       12.4 ± 0.3      15.7 ± 0.3      \<0.001
  MUFA (g)                    14.4 ± 0.4      17.8 ± 0.5      19.2 ± 0.5      21.4 ± 0.6      \<0.001   11.5 ± 0.3       12.2 ± 0.3       13.6 ± 0.3      15.8 ± 0.4      \<0.001
  PUFA (g)                    14.0 ± 0.4      14.9 ± 0.4      14.2 ± 0.4      12.4 ± 0.3      \<0.001   11.6 ± 0.3       10.4 ± 0.2       10.8 ± 0.3      9.5 ± 0.2       \<0.001
  n-3 Fatty acids (g)         2.3 ± 0.1       2.1 ± 0.1       1.8 ± 0.1       1.4 ± 0.0       \<0.001   2.0 ± 0.1        1.5 ± 0.0        1.5 ± 0.0       1.1 ± 0.0       \<0.001
  n-6 Fatty acids (g)         11.8 ± 0.4      12.9 ± 0.3      12.5 ± 0.3      11.1 ± 0.3      \<0.001   9.6 ± 0.2        8.9 ± 0.2        9.4 ± 0.3       8.4 ± 0.2       \<0.001
  Cholesterol (mg)            276.8 ± 9.1     311.0 ± 10.0    323.4 ± 10.0    339.2 ± 10.4    \<0.001   212.8 ± 5.9      221.6 ± 6.8      246.5 ± 6.6     268.7 ± 7.0     \<0.001
  Fiber (g)                   31.3 ± 0.6      29.3 ± 0.5      25.5 ± 0.4      18.5 ± 0.3      \<0.001   27.8 ± 0.4       24.8 ± 0.4       21.9 ± 0.3      16.7 ± 0.4      \<0.001
  Fe (mg)                     22.5 ± 1.2      22.5 ± 1.2      19.7 ± 0.4      17.6 ± 0.4      \<0.001   17.2 ± 0.4       16.1 ± 0.3       15.3 ± 0.2      13.8 ± 0.3      \<0.001
  Vitamin A (mg)              1338.8 ± 64.5   891.1 ± 26.9    688.2 ± 32.7    486.2 ± 11.3    \<0.001   1180.8 ± 40.4    723.8 ± 23.1     545.4 ± 15.8    401.1 ± 8.6     \<0.001
  Carotene (μg)               6960.6 ± 325    4278.7 ± 125    2985.1 ± 72.4   1958.3 ± 54.1   \<0.001   6324.1 ± 229.1   3568.4 ± 116.4   2418.6 ± 68.9   1527.1 ± 37.2   \<0.001
  Vitamin B~1~ (mg)           2.4 ± 0.0       2.5 ± 0.0       2.4 ± 0.0       2.3 ± 0.0       0.002     1.9 ± 0.0        1.9 ± 0.0        1.9 ± 0.0       1.7 ± 0.0       \<0.001
  Vitamin B~2~ (mg)           1.6 ± 0.0       1.7 ± 0.0       1.6 ± 0.0       1.6 ± 0.0       0.603     1.3 ± 0.0        1.3 ± 0.0        1.3 ± 0.0       1.3 ± 0.0       0.043
  Niacin (mg)                 19.7 ± 0.4      20.6 ± 0.4      20.3 ± 0.4      18.8 ± 0.4      0.004     15.7 ± 0.2       15 ± 0.2         15.3 ± 0.2      14.1 ± 0.2      \<0.001
  Vitamin C (mg)              137.7 ± 4.3     112.8 ± 4.3     85.0 ± 3.9      51.1 ± 1.9      \<0.001   146.1 ± 4.1      131.4 ± 4.9      102.5 ± 3.9     57.7 ± 2.3      \<0.001
  Garlic (g)                  10.5 ± 0.7      7.8 ± 0.4       7.3 ± 0.5       4.9 ± 0.3       \<0.001   6.8 ± 0.3        5.8 ± 0.3        4.6 ± 0.3       2.6 ± 0.1       \<0.001
  Ginger (g)                  0.6 ± 0.0       0.8 ± 0.2       0.6 ± 0.1       0.4 ± 0.0       0.001     0.4 ± 0.1        0.4 ± 0.0        0.3 ± 0.0       0.2 ± 0.0       0.006
  Onion (g)                   39.4 ± 1.7      38.4 ± 1.7      36.7 ± 2.6      26.7 ± 1.3      \<0.001   31.5 ± 1.4       27.4 ± 1.1       22.6 ± 1.2      18.7 ± 1.1      \<0.001
  Green/black tea (g)         49.4 ± 7.0      20.6 ± 3.8      16.7 ± 5.8      6.5 ± 3.5       \<0.001   53.9 ± 7.9       23.3 ± 3.9       15.5 ± 3.0      4.0 ± 1.5       \<0.001
  Pepper (g)                  53.5 ± 2.8      44.2 ± 2.0      33.2 ± 1.3      21.7 ± 1.1      \<0.001   43 ± 2.0         30.1 ± 1.2       22.8 ± 1.2      12.5 ± 0.6      \<0.001

DII: dietary inflammatory index; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids. All analyses accounted for the complex sampling design and appropriate sampling weights of the national survey. Data are expressed as the number of subjects for each category (weighted percentage) or means ± SE (standard error). ^1^ *p*-values are from ANOVA test.
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###### 

Odds ratio of metabolic syndrome and its components by DII quartiles.

                         Men         Women                                                                                         
  ---------------------- ----------- ----------- ------------------ ------------------ ----------- ------------ ------------------ ------------------
  Metabolic syndrome                                                                                                               
  Q1                     283(26.0)   637(23.1)   1.00(ref.)         1.00(ref.)         261(26.4)   1142(23.2)   1.00(ref.)         1.00(ref.)
  Q2                     244(22.5)   677(25.2)   0.80(0.64--0.99)   0.98(0.76--1.27)   240(23.8)   1162(24.3)   0.86(0.69--1.07)   0.88(0.68--1.26)
  Q3                     272(25.9)   648(24.2)   0.95(0.76--1.20)   1.25(0.96--1.64)   238(24.2)   1164(25.4)   0.84(0.67--1.05)   1.02(0.78--1.34)
  Q4                     244(25.6)   677(27.5)   0.83(0.66--1.04)   1.40(1.06--1.85)   227(25.5)   1175(27.0)   0.83(0.66--1.04)   1.22(0.91--1.64)
  *p* for trend ^3^                              0.232              0.008                                       0.120              0.180
  Central obesity                                                                                                                  
  Q1                     278(27.0)   642(22.7)   1.00(ref.)         1.00(ref.)         239(22.2)   1164(24.0)   1.00(ref.)         1.00(ref.)
  Q2                     233(22.5)   688(25.2)   0.75(0.60--0.94)   0.91(0.64--1.31)   273(24.8)   1129(24.1)   1.11(0.91--1.36)   1.19(0.86--1.64)
  Q3                     274(26.8)   646(23.9)   0.94(0.75--1.19)   1.28(0.89--1.85)   262(24.8)   1140(25.3)   1.06(0.85--1.33)   1.28(0.90--1.83)
  Q4                     225(23.7)   696(28.2)   0.71(0.56--0.89)   1.07(0.72--1.61)   270(28.2)   1132(26.5)   1.15(0.93--1.42)   1.35(0.94--1.94)
  *p* for trend ^3^                              0.020              0.445                                       0.282              0.094
  Hypertension                                                                                                                     
  Q1                     389(26.5)   531(22.4)   1.00(ref.)         1.00(ref.)         397(29.4)   1006(22.2)   1.00(ref.)         1.00(ref.)
  Q2                     335(22.7)   586(25.5)   0.75(0.61--0.93)   0.85(0.68--1.07)   351(25.1)   1051(24.0)   0.79(0.65--0.96)   0.92(0.75--1.14)
  Q3                     360(24.9)   560(24.6)   0.86(0.69--1.06)   1.00(0.79--1.27)   313(23.0)   1089(25.8)   0.67(0.56--0.82)   0.89(0.73--1.10)
  Q4                     345(25.9)   576(27.6)   0.79(0.64--0.99)   1.14(0.88--1.46)   274(22.4)   1128(28.0)   0.61(0.50--0.74)   1.10(0.87--1.38)
  *p* for trend ^3^                              0.086              0.217                                       \<0.001            0.616
  Hypertriglyceridemia                                                                                                             
  Q1                     366(24.2)   554(23.6)   1.00(ref.)         1.00(ref.)         270(24.7)   1133(23.5)   1.00(ref.)         1.00(ref.)
  Q2                     363(23.8)   558(25.0)   0.93(0.76--1.14)   1.06(0.85--1.33)   270(24.1)   1132(24.3)   0.95(0.76--1.18)   1.01(0.81--1.27)
  Q3                     392(25.6)   528(24.1)   1.04(0.84--1.28)   1.19(0.95--1.49)   273(26.4)   1129(25.0)   1.01(0.82--1.24)   1.14(0.91--1.43)
  Q4                     368(26.5)   553(27.3)   0.95(0.77--1.17)   1.22(0.97--1.53)   247(24.7)   1155(27.3)   0.86(0.69--1.08)   1.07(0.84--1.38)
  *p* for trend ^3^                              0.848              0.061                                       0.272              0.418
  Hyperglycemia                                                                                                                    
  Q1                     384(26.9)   536(22.3)   1.00(ref.)         1.00(ref.)         371(27.6)   1032(22.7)   1.00(ref.)         1.00(ref.)
  Q2                     329(23.2)   592(25.2)   0.76(0.62--0.94)   0.90(0.71--1.14)   319(24.7)   1083(24.1)   0.84(0.69--1.02)   0.95(0.77--1.18)
  Q3                     338(23.6)   582925.2)   0.78(0.62--0.97)   0.97(0.76--1.24)   331(25.9)   1071(25.1)   0.85(0.71--1.01)   1.08(0.88--1.32)
  Q4                     333(26.2)   588(27.3)   0.79(0.65--0.97)   1.30(1.02--1.65)   271(21.8)   1131(28.1)   0.64(0.52--0.77)   0.95(0.77--1.18)
  *p* for trend ^3^                              0.037              0.038                                       \<0.001            0.914
  Low HDL-cholesterol                                                                                                              
  Q1                     250(26.5)   670(23.0)   1.00(ref.)         1.00(ref.)         586(27.2)   817(21.8)    1.00(ref.)         1.00(ref.)
  Q2                     235(24.9)   686(24.4)   0.89(0.70--1.12)   1.05(0.82--1.34)   514(23.5)   888(24.6)    0.76(0.65--0.90)   0.79(0.67--0.94)
  Q3                     231(26.1)   689(24.2)   0.94(0.75--1.17)   1.14(0.90--1.45)   495(23.9)   907(26.0)    0.74(0.62--0.88)   0.78(0.65--0.94)
  Q4                     186(22.5)   735(28.3)   0.69(0.55--0.87)   0.93(0.72--1.21)   497(25.4)   905(27.6)    0.74(0.62--0.87)   0.85(0.71--1.04)
  *p* for trend ^3^                              0.004              0.788                                       0.001              0.113

DII: dietary inflammatory index; OR: odds ratio; CI: confidence interval; ref., reference. All analyses accounted for the complex sampling design and appropriate sampling weights of the national survey. ^1^ The DII scores were categorized into quartiles for men (Q1: \<−0.16, Q2: −0.16--\<0.91, Q3: 0.91--\<1.89, Q4: ≥1.89) and for women (Q1: \<−0.85, Q2:-0.85--\<0.20, Q3: 0.20--\<1.28, Q4: ≥1.28). ^2^ Adjusted for age, BMI, education, alcohol consumption, smoking, physical activity, and total calorie intake. ^3^ *p* for linear trend was calculated using the median value of each quartile category as a continuous variable.
